Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalities.

Tracy I, Tapper W, Parker A, Gardiner A, Sadullah S, Pratt G, Copplestone A, Oscier D, Best OG.

Br J Haematol. 2016 Jun 13. doi: 10.1111/bjh.14172. [Epub ahead of print] No abstract available.

PMID:
27292869
2.

KNOWLEDGE AWARENESS AND BEHAVIOUR OF NON-MEDICAL STUDENTS ABOUT CARDIOVASCULAR DISEASES.

Mustaqeem M, Sadullah S, Farooq MZ, Waqar W, Fraz TR.

J Ayub Med Coll Abbottabad. 2015 Oct-Dec;27(4):894-9.

PMID:
27004348
3.

Obesity with irregular menstrual cycle in young girls.

Mustaqeem M, Sadullah S, Waqar W, Farooq MZ, Khan A, Fraz TR.

Mymensingh Med J. 2015 Jan;24(1):161-7.

PMID:
25725683
4.

Guidelines for the first line management of classical Hodgkin lymphoma.

Follows GA, Ardeshna KM, Barrington SF, Culligan DJ, Hoskin PJ, Linch D, Sadullah S, Williams MV, Wimperis JZ; British Committee for Standards in Haematology.

Br J Haematol. 2014 Jul;166(1):34-49. doi: 10.1111/bjh.12878. Epub 2014 Apr 9. No abstract available.

PMID:
24712411
5.

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.

Morgan GJ, Davies FE, Gregory WM, Szubert AJ, Bell SE, Drayson MT, Owen RG, Ashcroft AJ, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Studies Group.

Blood. 2012 Jun 7;119(23):5374-83. doi: 10.1182/blood-2011-11-392522. Epub 2012 Apr 12.

6.

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.

Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Navarro Coy N, Cook G, Feyler S, Johnson PR, Rudin C, Drayson MT, Owen RG, Ross FM, Russell NH, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Studies Group.

Haematologica. 2012 Mar;97(3):442-50. doi: 10.3324/haematol.2011.043372. Epub 2011 Nov 4.

7.

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

Morgan GJ, Gregory WM, Davies FE, Bell SE, Szubert AJ, Brown JM, Coy NN, Cook G, Russell NH, Rudin C, Roddie H, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Studies Group.

Blood. 2012 Jan 5;119(1):7-15. doi: 10.1182/blood-2011-06-357038. Epub 2011 Oct 20.

8.

Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2.

Subramaniya BR, Srinivasan G, Sadullah SS, Davis N, Subhadara LB, Halagowder D, Sivasitambaram ND.

PLoS One. 2011 Apr 29;6(4):e18695. doi: 10.1371/journal.pone.0018695.

9.

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.

Craddock C, Anson J, Chu P, Dodgson A, Duncan N, Gomez C, Mehta J, Sadullah S, Subudhi C, Yin JL.

Expert Opin Drug Saf. 2010 Jan;9(1):139-47. doi: 10.1517/14740330903418430. Review. Erratum in: Expert Opin Drug Saf. 2011 Mar;10(2):335.

PMID:
19947901
10.

The current role of amphotericin B lipid complex in managing systemic fungal infections.

Chu P, Sadullah S.

Curr Med Res Opin. 2009 Dec;25(12):3011-20. doi: 10.1185/03007990903379077. Review.

PMID:
19849324
11.

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

Burnett AK, Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K; United Kingdom National Cancer Research Institute Haematological Oncology Study Group.

Br J Haematol. 2009 May;145(3):318-32. doi: 10.1111/j.1365-2141.2009.07604.x. Epub 2009 Mar 8.

PMID:
19291085
12.

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.

Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S; RECORD2 Investigators.

Lancet. 2008 Jul 5;372(9632):31-9. doi: 10.1016/S0140-6736(08)60880-6. Epub 2008 Jun 24.

PMID:
18582928
13.

Mosaic trisomy 2 in myelodysplastic syndromes and acute myeloblastic leukemias.

Czepulkowski B, Saunders K, Pocock C, Sadullah S.

Cancer Genet Cytogenet. 2003 Aug;145(1):78-81.

PMID:
12885468
14.

Recurrent septicaemia in a neutropenic patient with typhlitis.

Sadullah S, Nagesh K, Johnston D, McCullough JB, Murray F, Cachia PG.

Clin Lab Haematol. 1996 Sep;18(3):215-7.

PMID:
8939393
15.

Fetal blood ferritin and cobalamin in normal pregnancy.

Abbas A, Snijders RJ, Sadullah S, Nicolaides KH.

Fetal Diagn Ther. 1994 Jan-Feb;9(1):14-8.

PMID:
8142047
16.

A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer.

Hamblin TJ, Sadullah S, Williamson P, Stevenson J, Oskam R, Palmer P, Franks CR.

Br J Cancer. 1993 Dec;68(6):1186-9.

17.

Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome.

Kruger A, Sadullah S, Chapman R, Hodges E, Mould S, Hamblin TJ, Oscier DG.

Leukemia. 1993 Nov;7(11):1891-5. Review.

PMID:
8231258
18.

A patient with monosomy 7 and polyuria.

Sadullah S, Kruger AR, Barrington Onslow S, Armitage M, Oscier DG.

Leuk Res. 1992 Jun-Jul;16(6-7):711-5.

PMID:
1635385
19.

Use of Mesterolone, a non-alkylated anabolic steroid, in myelofibrosis.

Sadullah S, Kruger A, Clarke N, Bell A.

Clin Lab Haematol. 1992;14(4):335-6. No abstract available.

PMID:
1478014
20.

A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma.

Hamblin TJ, Inzani V, Sadullah S, Stevenson FK, Williamson P, van der Plas J, Palmer P, Franks CR.

Cancer Treat Rev. 1989 Jun;16 Suppl A:163-7.

PMID:
2670212
Items per page

Supplemental Content

Loading ...
Write to the Help Desk